Company Filing History:
2 out of 1,928 
2 out of 3,687 
Years Active: 2018
Title: Khadiza Chowdhury: Innovator in Cancer Treatment
Introduction
Khadiza Chowdhury is a prominent inventor based in San Jose, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of 2 patents, her work focuses on enhancing the effectiveness of cancer therapies.
Latest Patents
Khadiza's latest patents include groundbreaking methods aimed at sensitizing cancer cells to treatment. The first patent, titled "Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in ovarian cancer," outlines techniques for treating cancer cells using low doses of DNA demethylating agents alongside poly ADP ribose polymerase (PARP) inhibitors. This method also provides strategies for sensitizing cells to PARP inhibitors. The second patent, similarly titled "Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in lung cancer," presents analogous methods for lung cancer treatment, emphasizing the potential of these therapies in various cancer types.
Career Highlights
Khadiza has worked with esteemed institutions such as the University System of Maryland and The Johns Hopkins University. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her research capabilities.
Collaborations
Some of her notable coworkers include Feyruz Rassool and Stephen B Baylin. Their collaborative efforts have contributed to the advancement of cancer treatment methodologies.
Conclusion
Khadiza Chowdhury's innovative work in cancer treatment exemplifies the impact of research and invention in the medical field. Her patents reflect a commitment to improving therapeutic strategies for cancer patients.